DaVita Quarterly Income Statement
NYSE: DVAHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
DaVita revenue and earnings
In the quarter ended Jun 30, 2026, DaVita generated $3.55 billion in revenue, up 5.2% from the same quarter a year earlier. Net income was $265.4 million (+33.1% year over year), for a net margin of 7.5% versus a median of 5.8% in the prior 5 quarters. Operating margin was 16.3%.
Diluted earnings per share came in at $4.02, up from $2.58.
Summary generated from market data by MetaCap's automated system. Methodology
DaVita income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.55B | 3.42B | 3.62B | 3.42B | 3.38B | 3.22B | 3.29B | 3.26B | 3.19B | 3.07B | 3.15B | 3.12B |
| Revenue growth (YoY) | +5.17% | +5.96% | +9.87% | +4.80% | +6.05% | +4.98% | +4.73% | +4.56% | +6.21% | +6.89% | +7.85% | +5.85% |
| Operating Income | 579.00M | 481.89M | 561.07M | 505.77M | 537.84M | 438.94M | 565.36M | 534.88M | 506.40M | 483.85M | 389.91M | 495.94M |
| Interest Expense | 150.26M | 145.13M | 148.25M | 150.56M | 146.06M | 135.06M | 138.72M | 134.58M | 97.75M | 99.42M | 96.19M | 98.08M |
| Other Income (Expense) | 8.30M | 4.47M | -21.03M | -41.26M | -22.85M | -17.55M | -12.91M | -16.78M | -27.48M | -12.64M | -4.65M | -19.65M |
| Pretax Income | 435.01M | 341.23M | 382.76M | 308.80M | 368.93M | 286.33M | 413.73M | 373.43M | 371.44M | 371.79M | 289.07M | 378.21M |
| Income Tax | 91.79M | 66.20M | 76.73M | 68.55M | 93.71M | 54.12M | 64.49M | 77.67M | 71.69M | 65.81M | 58.49M | 68.85M |
| Net Income | 265.40M | 197.53M | 234.22M | 150.33M | 199.34M | 162.92M | 259.33M | 214.69M | 222.68M | 239.65M | 150.66M | 246.63M |
| Net Income growth (YoY) | +33.14% | +21.25% | -9.68% | -29.98% | -10.48% | -32.02% | +72.12% | -12.95% | +24.62% | +107.40% | +121.23% | +134.07% |
| EPS (Basic) | 4.10 | 2.93 | 3.30 | 2.09 | 2.62 | 2.05 | 3.17 | 2.56 | 2.56 | 2.73 | 1.68 | 2.70 |
| EPS (Diluted) | 4.02 | 2.87 | 3.22 | 2.04 | 2.58 | 2.00 | 3.08 | 2.50 | 2.50 | 2.65 | 1.64 | 2.62 |
| Shares Outstanding (Basic) | 64.78M | 67.39M | — | 72.08M | 75.94M | 79.37M | — | 83.72M | 86.90M | 87.78M | — | 91.32M |
| Shares Outstanding (Diluted) | 66.09M | 68.88M | — | 73.77M | 77.36M | 81.28M | — | 85.80M | 88.95M | 90.55M | — | 94.04M |
| EBITDA | 746.81M | 659.72M | 747.77M | 683.26M | 712.54M | 615.39M | 739.46M | 721.89M | 682.06M | 670.93M | 585.19M | 684.36M |
| Operating Margin | 16.29% | 14.11% | 15.50% | 14.79% | 15.91% | 13.62% | 17.16% | 16.39% | 15.89% | 15.76% | 12.39% | 15.89% |
| Net Margin | 7.47% | 5.78% | 6.47% | 4.40% | 5.90% | 5.05% | 7.87% | 6.58% | 6.99% | 7.80% | 4.79% | 7.90% |
This table shows 12 quarterly periods of DaVita's income statement, from Q2 2026 back to Q3 2023, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow DVA's reporting calendar. What is a income statement?